Inclusive Leadership at the Top

At Centrient Pharmaceuticals, board diversity is a strategic imperative—one that strengthens our governance, sharpens our decision-making, and positions us to lead with purpose in a rapidly evolving global landscape. 

We believe that a high-performing Board of Directors reflects the complexity of the world we serve. By bringing together leaders with varied backgrounds, expertise, and perspectives, we unlock richer dialogue, more agile thinking, and a deeper understanding of the societal and environmental forces shaping our industry. This diversity of thought is essential to guiding long-term strategy, managing risk, and ensuring accountability across our ESG priorities. 

Our Board brings together executive and non-executive directors with complementary expertise—from operational leadership to strategic oversight. This diversity strengthens governance, supports informed decision-making, and ensures we remain aligned with the needs of our stakeholders.

Centrient's commitments 

Centrient is committed to fostering diversity within its Board of Directors, recognizing that varied backgrounds and perspectives strengthen governance and decision-making. By ensuring diverse representation at the highest level, we create a more inclusive leadership environment that enhances oversight and accountability. Our Board of Directors and Executive Committee—reflecting this diversity—jointly oversee the compliance framework, which is designed to promote responsible and inclusive business management practices. Centrient has set the following Board diversity target in its ESG strategy: 

• Maintain diverse members at Board of Directors level, with at least 33% female and at least 33% male representation

   

What we achieved in 2024 

• Achieving 37.5% female and 62.5% male representation on the Board